Medical Economics October 11, 2023
AI is part of it, but not the only factor as physicians and patients interact with computers.
The U.S. Food and Drug Administration (FDA) is forming an advisory committee to guide use of new digital technologies in medicine.
FDA is seeking nominations for a nine-member group to weigh in on artificial intelligence/machine learning (AI/ML), augmented reality, virtual reality, digital therapeutics, wearables, remote patient monitoring and software. FDA announced the formation on Oct. 11 and will collect applications through Dec. 11.
The new Digital Health Advisory Committee will advise the commissioner of food and drugs about the technologies. Issues will include benefits, risks and clinical outcomes involved with use of digital health technologies (DHTs), along with risks, barriers or unintended consequences...
Today's Sponsors
Today's Sponsor